Radium

Waukesha’s Great Water Alliance Program Solves Public Health Crisis

Retrieved on: 
Thursday, November 9, 2023
Water supply, Groundwater, Water, Colorado River Compact, WWU, Great Lakes Compact, City, Great Lakes, Great Lakes region, Drinking water, St. Peter Sandstone, Partnership, Public, Radium, Lake Michigan, Great

This accomplishment marks a defining moment in safeguarding public health, environmental stewardship, and long-term water security for Waukesha’s 72,000 residents.

Key Points: 
  • This accomplishment marks a defining moment in safeguarding public health, environmental stewardship, and long-term water security for Waukesha’s 72,000 residents.
  • It also sets an industry precedent for solving water quality and scarcity challenges in at-risk communities across the Great Lakes region.
  • The Great Water Alliance Program, with its adaptable and forward-thinking approach, set new standards for community engagement, agency collaboration, and engineering excellence.
  • It is not just a water infrastructure project; it’s a groundbreaking model that will influence future water supply initiatives and regional programs.

New Beginnings: Dive into Parenthood with Waterdrop RO Hot Cold Dispenser A1--a Must-have for New Parents

Retrieved on: 
Wednesday, November 1, 2023
Taste, Child, Water, Temperature, Health, RO, Coffee, Quality of life, Drinking water, PFAS, Chromium, Lead, Arsenic, Safety, Water quality, Calcium, Tea, Radium, Parent, Iron, Heating, ventilation, and air conditioning

They rolled out RO Hot Cold Dispenser A1 , which tailored specifically for the needs of new parents, including expectant parents and those with infants or toddlers, with all-in-one functions to meet new parents' needs for controlling water temperature, improving water quality, and feeding at night conveniently.

Key Points: 
  • They rolled out RO Hot Cold Dispenser A1 , which tailored specifically for the needs of new parents, including expectant parents and those with infants or toddlers, with all-in-one functions to meet new parents' needs for controlling water temperature, improving water quality, and feeding at night conveniently.
  • New parents, in particular, have high expectations of water quality and always manage to provide quality of life and care for their babies.
  • There is a smart display with reminder function, users can more conveniently know the lifespan of the water filter.
  • A1 hot and cold water dispenser provides a user-friendly experience by displaying water quality, volume, temperature, and filter life at a glance.

Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023

Retrieved on: 
Thursday, October 12, 2023
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Congress, Disease, Trifluridine/tipiracil, Hepatocellular carcinoma, NSCLC, PLT, ORR, Bevacizumab, Observational study, Liver transplantation, Safety, Lung cancer, Mutation, RAS, Metastasis, Cancer, NTRK, European Society for Medical Oncology, ESMO, FDA, Prostate-specific antigen, Docetaxel, Quality of life (healthcare), Radium, Phase, REG, BAY, ADT, Patient, PSA, CNS, HCC, TRK, Radium-223, TKI, Pharmaceutical industry, Bayer

Bayer will present new data from across its oncology portfolio at the upcoming European Society for Medical Oncology (ESMO) Congress taking place in Madrid, Spain from October 20-24, 2023.

Key Points: 
  • Bayer will present new data from across its oncology portfolio at the upcoming European Society for Medical Oncology (ESMO) Congress taking place in Madrid, Spain from October 20-24, 2023.
  • The breadth of new data showcases Bayer’s ongoing commitment to supporting patients living with cancer.
  • In addition, Bayer will present new data on health-related quality of life (HRQoL) deterioration-free survival (DetFS) by PSA decline in the Phase III ARAMIS trial in patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
  • Details on presentations from Bayer for the 2023 ESMO Congress are listed below:
    Regorafenib (REG) in patients (pts) with unresectable hepatocellular carcinoma (uHCC) in real-world (RW) practice: Final analysis of the prospective, observational REFINE study by prior liver transplantation (PLT)

Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer

Retrieved on: 
Tuesday, September 12, 2023
Business development, University, Doctor of Philosophy, Pharmacy, Marketing, RDEB, Bristol Myers Squibb, Concha bullosa, CCO, Radium, Bayer, Publication, Triple accreditation, Lisocabtagene maraleucel, Harvard Business School, BMS, BD, Pharmaceutical industry

CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D., M.B.A. to the role of Chief Commercial Officer (CCO) and Head of Business Development (BD), effective immediately.

Key Points: 
  • CLEVELAND, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the appointment of Madhav Vasanthavada, Ph.D., M.B.A. to the role of Chief Commercial Officer (CCO) and Head of Business Development (BD), effective immediately.
  • Over the past year, as Abeona’s Head of BD, Dr. Vasanthavada’s efforts to assess EB-101’s commercial opportunity informed the Company’s strategy to prepare for a U.S. commercial launch without depending on a partner.
  • “Madhav’s appointment as Chief Commercial Officer is timely as Abeona prepares for the transition into a commercial-stage organization with the potential approval and launch of EB-101 in the U.S. next year,” said Vish Seshadri, Chief Executive Officer of Abeona.
  • He began his career as a scientist in Novartis R&D where his work led to multiple patents and publications.

The Forefront of Radiopharmaceuticals: History of α-Emitters with a Focus on Radiobiology, Physics and Clinical Considerations, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, September 5, 2023
University, College of Medicine, University of Cincinnati, Molecular imaging, Alliance of Independent Academic Medical Centers, Radiation, Radiopharmaceutical, Doctor of Philosophy, Radium, Medical physicist, MD, Pennsylvania State University Radiation Science & Engineering Center, Medpace, AC, Safety, Medical imaging

TORONTO, Sept. 5, 2023 /PRNewswire-PRWeb/ -- CRO and Biotech Discuss Advancements in Radiotherapy

Key Points: 
  • There are recent reports showing impressive safety and tumor response with α-particle therapy across many solid tumor populations.
  • In an upcoming webinar, Medpace Radiation Oncologist, Radiation Clinical Pharmacologist, are joined by a biotech Molecular Imaging Director, and Academic Medical Physicist to cover considerations in α-particle therapy.
  • There are recent reports showing impressive safety and tumor response with α-particle therapy across many solid tumor populations.
  • Click here to learn more about Medpace' s radiation therapy, radiopharmaceutical and radiation oncology solutions.

World Water Treatment Systems Market Trends Analysis Report 2023-2030: Water Scarcity Challenges Propel Adoption of Water Treatment Systems in Emerging Economies - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 16, 2023
Technology, Other Manufacturing, Other Technology, Manufacturing, Urbanization, Human, Waterborne diseases, United Nations, Drinking water, Health, Water pollution, DuPont, City, Magnesium, Telephone numbers in Hungary, Fatality, Power over Ethernet, Water cycle, USD, PES, Water supply, Kent RO Systems, Calcium, Natural Resources, CDC, Radium, RO, Flood, Sanitation, Water, Korea Disease Control and Prevention Agency, Groundwater, Growth, Commercial, WHO, Transport, POU, Phosphorus, Potassium, Safety, Sewage treatment, Agriculture, Pharmaceutical industry

The rising level of contaminants in water sources worldwide is expected to drive the global demand for water treatment systems to ensure a safe water supply.

Key Points: 
  • The rising level of contaminants in water sources worldwide is expected to drive the global demand for water treatment systems to ensure a safe water supply.
  • According to the United Nations World Water Development Report, the metropolitan population tackling water scarcity is expected to increase from 930 million in 2016 to between 1.7 and 2.4 billion people in 2050.
  • The growth in the urban population is rampant in emerging economies with limited capacity and other restraints on natural resources and creating water stress.
  • Water scarcity, floods, and poor water quality affect emerging economies, such as India, Brazil, and China, disproportionately.

RespireRx Pharmaceuticals Inc. and ResolutionRx Ltd Enter into Bilateral Agreements to Establish ResolutionRx Ltd as an Operating Company

Retrieved on: 
Wednesday, August 9, 2023
Transfer, Radium, Communication, Second Amendment to the United States Constitution, Australian Company Number, University, Senior, Ingenu, Letter of intent, Intellectual property, Service, CSO, Research, License, Securities and Exchange Commission (Philippines), LOI, Sale, End-user license agreement, Patent, Hale v. Committee on Character and Fitness for the State of Illinois, University of Illinois Urbana-Champaign, Trustee, OTC, Security (finance), MISA, Letter, Obstructive sleep apnea, RespireRx, Pharmaceutical industry

The Exclusive License permits the sublicensor to grant written sublicenses of its rights under the Exclusive License.

Key Points: 
  • The Exclusive License permits the sublicensor to grant written sublicenses of its rights under the Exclusive License.
  • The Sublicense is essentially a direct pass-through of all of the rights and obligations associated with the Exclusive License to ResolutionRx as sublicensee from RespireRx as sublicensor.
  • In consideration for the License and Sublicense, ResolutionRx issued 25,000,000 Ordinary Shares of ResolutionRx to RespireRx pursuant to a stock transfer agreement plus the payment of US$1 to RespireRx.
  • Our service agreements with RespireRx and iNGENu will provide the needed infrastructure for operations that have recently begun.

KING Coin's KING Pay Aims to Revolutionize Global Crypto Payments Landscape

Retrieved on: 
Saturday, July 22, 2023
Icos, Radium, Growth, KING, Community, VC, Social media, B2C, Cryptocurrency

Small Memecoin Gains Momentum with Strategic Entry into Global Markets

Key Points: 
  • Hong Kong, Hong Kong--(Newsfile Corp. - July 21, 2023) - KING Coin, a community-driven cryptocurrency that aims to revolutionize the crypto payments landscape, has released its comprehensive whitepaper outlining its unique approach to the market.
  • KING Coin's journey began as a meme coin but has since transformed into a community-driven entity in the crypto world.
  • KING Pay serves as the primary utility for KING Coin, offering a robust crypto payment gateway for both online and offline businesses.
  • With KING Pay and KING Wallet leading the way, KING Coin aims to revolutionize the world of crypto payments, fostering a more accessible and inclusive future for all.

International Photodynamic Association Announces 2023 Award Recipients in Tampere, Finland

Retrieved on: 
Monday, July 17, 2023
Science, Biotechnology, Research, Oncology, Health, Medical Devices, Infectious Diseases, Clinical Trials, Radium, Faculty, Infection, UCL, PIT, University, PD, PDT, PDD, Government, MICHAEL, McMaster Faculty of Health Sciences, IPA, Congress, Student, Outline of health sciences, University of Johannesburg, Diagnosis, Hospital, Photodynamic therapy, Institute for Cancer Research, Pharmaceutical industry, Forestry

The IPA World Congress featured research on a number of areas that use light-activated photosensitizers, including photodynamic therapy (PDT), antimicrobial photodisinfection, photoimmunotherapy (PIT), photodiagnosis (PD), etc.

Key Points: 
  • The IPA World Congress featured research on a number of areas that use light-activated photosensitizers, including photodynamic therapy (PDT), antimicrobial photodisinfection, photoimmunotherapy (PIT), photodiagnosis (PD), etc.
  • The International Photodynamic Association (IPA) was founded in 1986 to support and endorse the scientific advancement and clinical development of photomedicine, in particular in the areas of photodynamic disinfection, photodynamic therapy (PDT), photoimmunotherapy (PIT), and photodiagnosis (PD).
  • For more information, please go to the site: International Photodynamic Association (IPA)
    The Biennial International Photodynamic Association World Congress aims to bring together researchers and clinicians in all fields of Photodynamic Therapy (PDT) and Photodiagnosis (PDD) since 1986.
  • The 18th IPA World Congress will be held in Tampere, Finland , July 10-15, 2023.

POINT Biopharma and AdvanCell to Collaborate in the Development of Lead-212-Labeled Radioligands

Retrieved on: 
Monday, June 26, 2023
Maintenance, Radiation, Half-life, Thorium, Radiopharmaceutical, Radium, Neoplasm, Isotope, Pharmaceutical industry, Medical imaging

212Pb is produced via a generator using thorium (228Th, 1.9 year half-life) or radium (224Ra, 3.6 day half-life) sources.

Key Points: 
  • 212Pb is produced via a generator using thorium (228Th, 1.9 year half-life) or radium (224Ra, 3.6 day half-life) sources.
  • The short half-life may also promote the earlier maintenance of functional immune cells infiltrating the tumor relative to longer-lived isotopes.
  • “AdvanCell was founded on the belief that targeted alpha therapies will change the course of cancer treatment.
  • As AdvanCell progresses ADVC001, our lead clinical program for the treatment of metastatic prostate cancer, this collaboration will accelerate clinical development and ensure the scaled supply of these important medicines.”